Cited by 54Retinal Diseases and TreatmentsClusterin in disease pathologyRetinal Development and Disorders

Clusterin is Present in Drusen in Age-related Macular Degeneration

Sakaguchi, Hirokazu, Miyagi, Masaru, Shadrach, Karen G., Rayborn, Mary E., Crabb, John W., Hollyfield, Joe G.·2002·Experimental Eye Research

Integrity signals

Registry

Crossref · 10.1006/exer.2002.1186

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Immunocytochemical evidence supports the existence of annexins I and VI, calgranulin A and B, psoriasin, clusterin, and tissue metalloproteinase inhibitor 3 in drusen.

    “we have obtained immunocytochemical evidence supporting the existence of the following proteins in drusen: annexins I and VI, calgranulin A and B, psoriasin (Figs. 4 and 5, which are published as supporting information on the PNAS web site), clusterin (20), and TIMP3 (12).”

Cites

Flagged first, then by citations

2 of the 25 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Sakaguchi, H., Miyagi, M., Shadrach, K. G., Rayborn, M. E., Crabb, J. W., & Hollyfield, J. G.
Affiliations
Cleveland Clinic (US)
Venue
Experimental Eye Research
Publisher
Elsevier BV
Published
2002-04
Volume
74
Issue
4
Pages
547-549
ISSN
0014-4835 (ISSN-L)
OpenAlex
W1971967380
Cited by
54
References
25
Citations by year
2024: 2 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 2 · 2018: 1 · 2017: 2 · 2016: 1 · 2014: 2 · 2013: 3 · 2012: 7
FWCI
1.46
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental Eye Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ey002362-23)
  • National Eye Institute (R01 EY 06603, R01EY006603, EY 02362)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Oncology › Clusterin in disease pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
Keywords
clusterin, drusen, age-related macular degeneration, retinal pigment epithelium, protein secretion, extracellular matrix, choroid, endoplasmic reticulum stress, protein aggregation, gene therapy, cell therapy
MeSH terms
Glycoproteins, Humans, Macular Degeneration, Retinal Drusen, Molecular Chaperones, Clusterin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review